CLINICAL_TRIALS
trial_result
· 2026-03-19
Clinical Trial Update: Adjunctive Methylene Blue in Septic Shock [Phase 3]
Summary
Phase 3 trial evaluating adjunctive methylene blue for septic shock has completed with status listed as COMPLETED.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dr. Shannon M. Fernando | Conditions: Septic Shock | Phase 3 | Status: COMPLETED